Advertisement

Fetal imaging: Executive Summary of a Joint Eunice Kennedy Shriver National Institute of Child Health and Human Development, Society for Maternal-Fetal Medicine, American Institute of Ultrasound in Medicine, American College of Obstetricians and Gynecologists, American College of Radiology, Society for Pediatric Radiology, and Society of Radiologists in Ultrasound Fetal Imaging Workshop

      Given that practice variation exists in the frequency and performance of ultrasound and magnetic resonance imaging in pregnancy, the Eunice Kennedy Shriver National Institute of Child Health and Human Development hosted a workshop to address indications for ultrasound and magnetic resonance imaging in pregnancy, to discuss when and how often these studies should be performed, to consider recommendations for optimizing yield and cost-effectiveness and to identify research opportunities. This article is the executive summary of the workshop.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. American College of Radiology. ACR–ACOG–AIUM–SRU practice guideline for the performance of obstetrical ultrasound. Revised 2013 (Resolution 17). Available at: http://www.acr.org/∼/media/F7BC35BD59264E7CBE648F6D1BB8B8E2.pdf. Accessed Feb. 19, 2014.

        • American College of Obstetricians and Gynecologists
        Ultrasonography in pregnancy. ACOG Practice Bulletin no. 101.
        Obstet Gynecol. 2009; 113: 451-461
        • Society for Maternal Fetal Medicine
        White paper on ultrasound code 76811.
        SMFM, Washington, DC2012
        • National Collaborating Centre for Women's and Children's Health
        Antenatal care: routine care for the healthy pregnant woman.
        RCOG Press, London2008
        • Cargill Y.
        • Morin L.
        • Bly S.
        • et al.
        Content of a complete routine second trimester obstetrical ultrasound examination and report.
        J Obstet Gynaecol Can. 2009; 31: 272-280
        • Wilcox A.J.
        • Baird D.D.
        • Weinberg C.R.
        Time of implantation of the conceptus and loss of pregnancy.
        N Engl J Med. 1999; 340: 1796-1799
        • Wegienka G.
        • Baird D.D.
        A comparison of recalled date of last menstrual period with prospectively recorded dates.
        J Womens Health. 2005; 14: 248-252
        • Verburg B.O.
        • Steegers E.A.
        • De Ridder M.
        • et al.
        New charts for ultrasound dating of pregnancy and assessment of fetal growth: longitudinal data from a population-based cohort study.
        Ultrasound Obstet Gynecol. 2008; 31: 388-396
        • Whitworth M.
        • Bricker L.
        • Neilson J.P.
        • Dowswell T.
        Ultrasound for fetal assessment in early pregnancy.
        Cochrane Database Syst Rev. 2010; 4: CD007058
        • Taipale P.
        • Hiilesmaa V.
        Predicting delivery date by ultrasound and last menstrual period in early gestation.
        Obstet Gynecol. 2001; 97: 189-194
        • Robinson H.P.
        • Fleming J.E.
        A critical evaluation of sonar “crown–rump length” measurements.
        BJOG. 1975; 82: 702-710
        • Tunon K.
        • Eik-Ness S.H.
        • Grottum P.
        • Von During V.
        • Kahn J.A.
        Gestational age in pregnancies conceived after in vitro fertilization: a comparison between age assessed from oocyte retrieval, crown-rump length and biparietal diameter.
        Ultrasound Obstet Gynecol. 2000; 15: 41-46
        • Sladkevicius P.
        • Saltvedt S.
        • Almstrom H.
        • Kublickas M.
        • Grunewald C.
        • Valentin L.
        Ultrasound dating at 12-14 weeks of gestation: a prospective cross-validation of established dating formulae in in-vitro fertilized pregnancies.
        Ultrasound Obstet Gynecol. 2005; 26: 504-511
        • American College of Obstetricians and Gynecologists
        Screening for fetal chromosomal abnormalities. ACOG Practice Bulletin no. 77.
        Obstet Gynecol. 2007; 109: 217-227
        • Timor-Tritsch I.E.
        • Bashiri A.
        • Monteagudo A.
        • Arsland A.A.
        Qualified and trained sonographers in the US can perform early fetal anatomy scans between 11 and 14 weeks.
        Am J Obstet Gynecol. 2004; 191: 1247-1252
        • Souka A.P.
        • Pilalis A.
        • Kavalakis Y.
        • Kosmas Y.
        • Antsaklis P.
        • Antsaklis A.
        Assessment of fetal anatomy at the 11-14-week ultrasound examination.
        Ultrasound Obstet Gynecol. 2004; 24: 730-734
        • Syngelaki A.
        • Chelemen T.
        • Dagklis T.
        • Allan L.
        • Nicolaides K.H.
        Challenges in the diagnosis of fetal non-chromosomal abnormalities at 11-13 weeks.
        Prenat Diagn. 2011; 31: 90-102
        • den Hollander N.S.
        • Wessels M.W.
        • Niermeijer M.F.
        • Los F.J.
        • Wladimiroff J.W.
        Early fetal anomaly scanning in a population at increased risk of abnormalities.
        Ultrasound Obstet Gynecol. 2002; 19: 570-574
        • Whitlow B.J.
        • Economides D.L.
        The optimal gestational age to examine fetal anatomy and measure nuchal translucency in the first trimester.
        Ultrasound Obstet Gynecol. 1998; 11: 258-261
        • Doubilet P.M.
        • Benson C.B.
        Improved prediction of gestational age in the late third trimester.
        J Ultrasound Med. 1993; 12: 647-653
        • Benson C.B.
        • Doubilet P.M.
        Sonographic prediction of gestational age: accuracy of second- and third-trimester fetal measurements.
        AJR Am J Roentgenol. 1991; 157: 1275-1277
        • Chervenak F.A.
        • Skupski D.W.
        • Romero R.
        • et al.
        How accurate is fetal biometry in the assessment of fetal age?.
        Am J Obstet Gynecol. 1998; 178: 678-687
        • Hadlock F.P.
        • Deter R.L.
        • Harrist R.B.
        • Park S.K.
        Estimating fetal age: computer-assisted analysis of multiple fetal growth parameters.
        Radiology. 1984; 152: 497-501
        • Rosendahl H.
        • Kivenen S.
        Antenatal detection of congenital malformations by routine ultrasonography.
        Obstet Gynecol. 1989; 73: 947-951
        • Grandjean H.
        • Larroque D.
        • Levi S.
        The performance of routine ultrasonographic screening of pregnancies in the Eurofetus Study.
        Am J Obstet Gynecol. 1999; 181: 446-454
        • American Institute of Ultrasound in Medicine
        AIUM practice guideline for the performance of obstetric ultrasound examinations.
        J Ultrasound Med. 2013; 32: 1083-1101
        • Nyberg D.A.
        • Luthy D.A.
        • Resta R.G.
        • Nyberg B.C.
        • Williams M.A.
        Age-adjusted ultrasound risk assessment for fetal Down's syndrome during the second trimester: description of the method and analysis of 142 cases.
        Ultrasound Obstet Gynecol. 1998; 12: 8-14
        • Agathokleous M.
        • Chaveeva P.
        • Poon L.C.
        • Kosinski P.
        • Nicolaides K.H.
        Meta-analysis of second-trimester markers for trisomy 21.
        Ultrasound Obstet Gynecol. 2013; 41: 247-261
        • Bianchi D.W.
        • Platt L.D.
        • Goldberg J.D.
        • et al.
        Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing.
        Obstet Gynecol. 2012; 119: 890-901
        • Norton M.E.
        • Brar H.
        • Weiss J.
        • et al.
        Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18.
        Am J Obstet Gynecol. 2012; 207: 137.e1-137.e8
        • Palomaki G.E.
        • Kloza E.M.
        • Lambert-Messerlian G.M.
        • et al.
        DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study.
        Genet Med. 2011; 13: 913-920
        • Sepulveda W.
        • Lopez-Tenorio J.
        The value of minor ultrasound markers for fetal aneuploidy.
        Curr Opin Obstet Gynecol. 2001; 13: 183-191
        • Van den Hof M.C.
        • Wilson R.D.
        • Diagnostic Imaging Committee, Society of Obstetricians and Gynaecologists of Canada; Genetics Committee, Society of Obstetricians and Gynaecologists of Canada
        Fetal soft markers in obstetric ultrasound.
        J Obstet Gynaecol Can. 2005; 27: 592-636
        • Digiovanni L.M.
        • Quinlan M.P.
        • Verp M.S.
        Choroid plexus cysts: infant and early childhood developmental outcome.
        Obstet Gynecol. 1997; 90: 191-194
        • Bernier F.P.
        • Crawford S.G.
        • Dewey D.
        Developmental outcome of children who had choroid plexus cysts detected prenatally.
        Prenat Diagn. 2005; 25: 322-326
        • Coco C.
        • Jeanty P.
        Karyotyping of fetuses with isolated choroid plexus cysts is not justified in an unselected population.
        J Ultrasound Med. 2004; 23: 899-906
        • Bronsteen R.
        • Lee W.
        • Vettraino I.M.
        • Huang R.
        • Comstock C.H.
        Second-trimester sonography and trisomy 18: the significance of isolated choroid plexus cysts after an examination that includes the fetal hands.
        J Ultrasound Med. 2004; 23: 241-245
        • Demasio K.
        • Canterino J.
        • Ananth C.
        • Fernandez C.
        • Smulian J.
        • Vintxileos A.
        Isolated choroid plexus cyst in low-risk women less than 35 years old.
        Am J Obstet Gynecol. 2002; 187: 1246-1249
        • Rochon M.
        • Eddleman K.
        Controversial ultrasound findings.
        Obstet Gynecol Clin North Am. 2004; 31: 61-99
        • Dagklis T.
        • Plasencia W.
        • Maiz N.
        • Duarte L.
        • Nicolaides K.H.
        Choroid plexus cyst, intracardiac echogenic focus, hyperechogenic bowel and hydronephrosis in screening for trisomy 21 at 11 + 0 to 13 + 6 weeks.
        Ultrasound Obstet Gynecol. 2008; 31: 132-135
        • Sotiriadis A.
        • Makrydimas G.
        • Ioannidis J.P.
        Diagnostic performance of intracardiac echogenic foci for Down syndrome: a meta-analysis.
        Obstet Gynecol. 2003; 101: 1009-1016
        • Nyberg D.A.
        • Souter V.L.
        • El-Bastawissi A.
        • Young S.
        • Luthhardt F.
        • Luthy D.A.
        Isolated sonographic markers for detection of fetal Down syndrome in the second trimester of pregnancy.
        J Ultrasound Med. 2001; 20: 1053-1063
        • Coco C.
        • Jeanty P.
        • Jeanty C.
        An isolated echogenic heart focus is not an indication for amniocentesis in 12,672 unselected patients.
        J Ultrasound Med. 2004; 23: 489-496
        • Bromley B.
        • Lieberman E.
        • Shipp T.D.
        • Benacerraf B.R.
        The genetic sonogram: a method of risk assessment for Down syndrome in the second trimester.
        J Ultrasound Med. 2002; 21: 1087-1096
        • Achiron R.
        • Lipitz S.
        • Gabbay U.
        • Yagel S.
        Prenatal ultrasonographic diagnosis of fetal heart echogenic foci: no correlation with Down syndrome.
        Obstet Gynecol. 1997; 89: 945-948
        • Dildy G.A.
        • Judd V.E.
        • Clark S.L.
        Prospective evaluation of the antenatal incidence and postnatal significance of the fetal echogenic cardiac focus: a case-control study.
        Am J Obstet Gynecol. 1996; 175: 1008-1012
        • Wax J.R.
        • Donnelly J.
        • Carpenter M.
        • et al.
        Childhood cardiac function after prenatal diagnosis of intracardiac echogenic foci.
        J Ultrasound Med. 2003; 22: 783-787
        • Aagaard-Tillery K.M.
        • Malone F.D.
        • Nyberg D.A.
        • et al.
        Role of second trimester genetic sonography after Down syndrome screening.
        Obstet Gynecol. 2009; 114: 1189-1196
        • Corteville J.E.
        • Gray D.L.
        • Crane J.P.
        Congenital hydronephrosis: correlation of fetal ultrasonographic findings with infant outcome.
        Am J Obstet Gynecol. 1991; 165: 384-388
        • Carbone J.F.
        • Tuuli M.G.
        • Dicke J.M.
        • Macones G.A.
        • Odibo A.O.
        Revisiting the risk for aneuploidy in fetuses with isolated pyelectasis.
        Prenat Diagn. 2011; 31: 566-570
        • Signorelli M.
        • Cerri V.
        • Taddei F.
        • Groli C.
        • Bianchi U.A.
        Prenatal diagnosis and management of mild fetal pyelectasis: implications for neonatal outcome and follow-up.
        Eur J Obstet Gynecol Reprod Biol. 2005; 118: 154-159
        • Mallik M.
        • Watson A.R.
        Antenatally detected urinary tract abnormalities: more detection but less action.
        Pediatr Nephrol. 2008; 23: 897-904
        • Ismaili K.
        • Hall M.
        • Donner C.
        • et al.
        Results of systematic screening for minor degrees of fetal renal pelvis dilatation in an unselected population.
        Am J Obstet Gynecol. 2003; 188: 242-246
        • Goetzinger K.R.
        • Cahill A.G.
        • Macones G.A.
        • Odibo A.O.
        Isolated short femur length on second-trimester sonography: a marker for fetal growth restriction and other adverse perinatal outcomes.
        J Ultrasound Med. 2012; 31: 1935-1941
        • Weisz B.
        • David A.L.
        • Chitty L.
        • et al.
        Association of isolated short femur in the mid-trimester fetus with perinatal outcome.
        Ultrasound Obstet Gynecol. 2008; 31: 512-516
        • Salomon L.J.
        • Bernard J.P.
        • Taupin P.
        • Benard C.
        • Ville Y.
        Relationship between nuchal translucency at 11-14 weeks and nuchal fold at 20-24 weeks of gestation.
        Ultrasound Obstet Gynecol. 2001; 18: 636-637
        • Maymon R.
        • Zimerman A.L.
        • Weinraub Z.
        • Herman A.
        • Cuckle H.
        Correlation between nuchal translucency and nuchal skin-fold measurements in Down syndrome and unaffected fetuses.
        Ultrasound Obstet Gynecol. 2008; 32: 501-505
        • Mailath-Pokorny M.
        • Klein K.
        • Klembermass-Schrehof K.
        • Hachemian N.
        • Bettelheim D.
        Are fetuses with isolated echogenic bowel at higher risk for an adverse pregnancy outcome? Experiences from a tertiary referral center.
        Prenat Diagn. 2012; 32: 1295-1299
        • Goetzinger K.R.
        • Cahill A.G.
        • Macones G.A.
        • Odibo A.O.
        Echogenic bowel on second-trimester ultrasonography: evaluating the risk of adverse pregnancy outcome.
        Obstet Gynecol. 2011; 117: 1341-1348
        • Sepulveda W.
        • Sebire N.J.
        Fetal echogenic bowel: a complex scenario.
        Ultrasound Obstet Gynecol. 2000; 16: 510-514
        • Sepulveda W.
        • Leung K.Y.
        • Robertson M.E.
        • Kay E.
        • Mayall E.S.
        • Fisk N.M.
        Prevalence of cystic fibrosis mutations in pregnancies with fetal echogenic bowel.
        Obstet Gynecol. 1996; 87: 103-106
        • Nyberg D.A.
        • Dubinsky T.
        • Resta R.G.
        • Mahony B.S.
        • Hickok D.E.
        • Luthy D.A.
        Echogenic fetal bowel during the second trimester: clinical importance.
        Radiology. 1993; 188: 527-531
        • Sonek J.D.
        • Cicero S.
        • Neiger R.
        • Nicolaides K.H.
        Nasal bone assessment in prenatal screening for trisomy 21.
        Am J Obstet Gynecol. 2006; 195: 1219-1230
        • Cicero S.
        • Sonek J.D.
        • McKenna D.S.
        • Croom C.S.
        • Johnson L.
        • Nicolaides K.H.
        Nasal bone hypoplasia in trisomy 21 at 15–22 weeks gestation.
        Ultrasound Obstet Gynecol. 2003; 21: 15-18
        • Bromley B.
        • Lieberman E.
        • Shipp T.D.
        • Benacerraf B.R.
        Fetal nose bone length: a marker for Down syndrome in the second trimester.
        J Ultrasound Med. 2002; 21: 1387-1394
        • Odibo A.O.
        • Sehdev H.M.
        • Stamilio D.M.
        • Cahill A.
        • Dunn L.
        • Macones G.A.
        Defining nasal bone hypoplasia in second-trimester Down syndrome screening: does the use of multiples of the median improve screening efficacy?.
        Am J Obstet Gynecol. 2007; 197: 361.e1-361.e4
        • American College of Obstetricians and Gynecologists
        Obesity in pregnancy. Committee Opinion no. 549.
        Obstet Gynecol. 2013; 121: 213-217
        • Stothard K.J.
        • Tennant P.W.
        • Bell R.
        • Rankin J.
        Maternal overweight and obesity and the risk of congenital anomalies: a systematic review and meta-analysis.
        JAMA. 2009; 301: 636-650
        • Dashe J.S.
        • McIntire D.D.
        • Twickler D.M.
        Effect of maternal obesity on the ultrasound detection of anomalous fetuses.
        Obstet Gynecol. 2009; 113: 1001-1007
        • Aagaard-Tillery K.M.
        • Flint Porter T.
        • Malone F.D.
        • et al.
        Influence of maternal BMI on genetic sonography in the FaSTER trial.
        Prenat Diagn. 2010; 30: 14-22
        • Hendler I.
        • Blackwell S.C.
        • Bujold E.
        • et al.
        Suboptimal second-trimester ultrasonographic visualization of the fetal heart in obese women: should we repeat the examination?.
        J Ultrasound Med. 2005; 24: 1205-1209
        • Tsai L.J.
        • Ho M.
        • Pressman E.K.
        • Thornburg L.L.
        Ultrasound screening for fetal aneuploidy using soft markers in the overweight and obese gravida.
        Prenatal Diagn. 2010; 30: 821-826
        • Paladini D.
        Sonography in obese and overweight pregnant women: clinical, medicolegal and technical issues.
        Ultrasound Obstet Gynecol. 2009; 33: 720-729
        • Hendler I.
        • Blackwell S.C.
        • Bujold E.
        • et al.
        The impact of maternal obesity on midtrimester sonographic visualization of fetal cardiac and craniospinal structures.
        Int J Obes Relat Metab Disord. 2004; 28: 1607-1611
        • Fuchs F.
        • Houllier M.
        • Voulgaropoulos A.
        • et al.
        Factors affecting feasibility and quality of second-trimester ultrasound scans in obese pregnant women.
        Ultrasound Obstet Gynecol. 2013; 41: 40-46
        • Martin J.A.
        • Hamilton B.E.
        • Osterman M.J.
        Three decades of twin births in the United States, 1980-2009.
        NCHS Data Brief. 2012; 80: 1-8
        • Simpson L.L.
        • Society for Maternal-Fetal Medicine
        Twin-twin transfusion syndrome.
        Am J Obstet Gynecol. 2013; 208: 3-18
        • Wen S.W.
        • Fung K.F.
        • Huang L.
        • et al.
        Fetal and neonatal mortality among twin gestations in a Canadian population: the effect of intrapair birthweight discordance.
        Am J Perinatol. 2005; 22: 279-286
        • Breathnach F.M.
        • McAuliffe F.M.
        • Geary M.
        • et al.
        Definition of intertwin birth weight discordance.
        Obstet Gynecol. 2011; 118: 94-103
        • Kingdom J.C.
        • Nevo O.
        • Murphy K.E.
        Discordant growth in twins.
        Prenat Diagn. 2005; 25: 759-765
        • Faiz A.S.
        • Anath C.V.
        Etiology and risk factors for placenta previa: an overview and meta-analysis of observational studies.
        J Matern Fetal Neonatal Med. 2003; 13: 175-190
        • Frederiksen M.C.
        • Glassenberg R.
        • Stika C.S.
        Placenta previa: a 22-year analysis.
        Am J Obstet Gynecol. 1999; 180: 1432-1437
        • Iyasu S.
        • Saftlas A.K.
        • Rowley D.L.
        • Koonin L.M.
        • Lawson H.W.
        • Atrash H.K.
        The epidemiology of placenta previa in the United States, 1979 through 1987.
        Am J Obstet Gynecol. 1993; 168: 1424-1429
        • Timor-Tritsch I.E.
        • Yunis R.A.
        Confirming the safety of transvaginal sonography in patients suspected of placenta previa.
        Obstet Gynecol. 1993; 81: 742-744
        • Becker R.H.
        • Vonk R.
        • Mende B.C.
        • Ragosch V.
        • Entezami M.
        The relevance of placental location at 20–23 gestational weeks for prediction of placenta previa at delivery: evaluation of 8650 cases.
        Ultrasound Obstet Gynecol. 2001; 17: 496-501
        • Lauria M.R.
        • Smith R.S.
        • Treadwell M.C.
        • et al.
        The use of second-trimester transvaginal sonography to predict placenta previa.
        Ultrasound Obstet Gynecol. 1996; 8: 337-340
        • Dashe J.S.
        • McIntire D.D.
        • Ramus R.M.
        • Santos-Ramos R.
        • Twickler D.M.
        Persistence of placenta previa according to gestational age at ultrasound detection.
        Obstet Gynecol. 2002; 99: 692-697
        • Bhide A.
        • Prefumo F.
        • Moore J.
        • Hollis B.
        • Thilaganathan B.
        Placental edge to internal os distance in the late third trimester and mode of delivery in placenta praevia.
        BJOG. 2003; 110: 860-864
        • Matsubara S.
        • Ohkuchi A.
        • Kikkawa M.
        • et al.
        Blood loss in low-lying placenta: placental edge to cervical internal os distance of less vs. more than 2 cm.
        J Perinat Med. 2008; 36: 507-512
        • Bronsteen R.
        • Valice R.
        • Lee W.
        • Blackwell S.
        • Balasubramaniam M.
        • Comstock C.
        Effect of a low-lying placenta on delivery outcome.
        Ultrasound Obstet Gynecol. 2009; 33: 204-208
        • Vergani P.
        • Ornaghi S.
        • Pozzi I.
        • et al.
        Placenta previa: distance to internal os and mode of delivery.
        Am J Obstet Gynecol. 2009; 201: 266.e1-266.e5
        • Oppenheimer L.W.
        • Farine D.
        • Ritchie J.W.
        • Lewinsky R.M.
        • Tellford J.
        • Fairbanks L.A.
        What is a low-lying placenta?.
        Am J Obstet Gynecol. 1991; 165: 1036-1038
        • Bronsteen R.
        • Whitten A.
        • Balasubramanian M.
        • et al.
        Vasa previa: clinical presentations, outcomes, and implications for management.
        Obstet Gynecol. 2013; 122: 352-357
        • Oyelese Y.
        • Catanzarite V.
        • Prefumo F.
        • et al.
        Vasa previa: the impact of prenatal diagnosis on outcomes.
        Obstet Gynecol. 2004; 103: 937-942
        • Bhide A.
        • Thilaganathan B.
        Recent advances in the management of placenta previa.
        Curr Opin Obstet Gynecol. 2004; 16: 447-451
        • Belfort M.A.
        • Publications Committee, Society for Maternal-Fetal Medicine
        Placenta accreta.
        Am J Obstet Gynecol. 2010; 203: 430-439
        • Silver R.M.
        • Landon M.B.
        • Rouse D.J.
        • et al.
        Maternal morbidity associated with multiple repeat cesarean deliveries.
        Obstet Gynecol. 2006; 107: 1226-1232
        • Comstock C.H.
        • Lee W.
        • Vettraino I.M.
        • Bronsteen R.A.
        The early sonographic appearance of placenta accreta.
        J Ultrasound Med. 2003; 22 (quiz 24–6): 19-23
        • Timor-Tritsch I.E.
        • Monteagudo A.
        Unforeseen consequences of the increasing rate of cesarean deliveries: early placenta accreta and cesarean scar pregnancy. A review.
        Am J Obstet Gynecol. 2012; 207: 14-29
        • Guy G.P.
        • Peisner D.B.
        • Timor-Tritsch I.E.
        Ultrasonographic evaluation of uteroplacental blood flow patterns of abnormally located and adherent placentas.
        Am J Obstet Gynecol. 1990; 163: 723-727
        • Warshak C.R.
        • Eskander R.
        • Hull A.D.
        • et al.
        Accuracy of ultrasonography and magnetic resonance imaging in the diagnosis of placenta accreta.
        Obstet Gynecol. 2006; 108: 573-581
        • McLean L.A.
        • Heilbrun M.E.
        • Eller A.G.
        • Kennedy A.M.
        • Woodward P.J.
        Assessing the role of magnetic resonance imaging in the management of gravid patients at risk for placenta accreta.
        Acad Radiol. 2011; 18: 1175-1180
        • Dildy 3rd, G.A.
        • Lira N.
        • Moise Jr., K.J.
        • Riddle G.D.
        • Deter R.L.
        Amniotic fluid volume assessment: comparison of ultrasonographic estimates versus direct measurements with a dye-dilution technique in human pregnancy.
        Am J Obstet Gynecol. 1992; 167: 986-994
        • Magann E.F.
        • Chauhan S.P.
        • Kinsella M.J.
        • McNamara M.F.
        • Whitworth N.S.
        • Morrison J.C.
        Antenatal testing among 1001 patients at high risk: the role of ultrasonographic estimate of amniotic fluid volume.
        Am J Obstet Gynecol. 1999; 180: 1330-1336
        • Magann E.F.
        • Sanderson M.
        • Martin J.N.
        • Chauhan S.
        The amniotic fluid index, single deepest pocket, and two-diameter pocket in normal human pregnancy.
        Am J Obstet Gynecol. 2000; 182: 1581-1588
        • Nabhan A.F.
        • Abdelmoula Y.A.
        Amniotic fluid index versus single deepest vertical pocket as a screening test for preventing adverse pregnancy outcome.
        Cochrane Database Syst Rev. 2008; 3: CD006593
        • Hill L.M.
        • Breckle R.
        • Thomas M.L.
        • Fries J.K.
        Polyhydramnios: ultrasonically detected prevalence and neonatal outcome.
        Obstet Gynecol. 1987; 69: 21-25
        • Carlson D.E.
        • Platt L.D.
        • Medearis A.L.
        • Horenstein J.
        Quantifiable polyhydramnios: diagnosis and management.
        Obstet Gynecol. 1990; 75: 989-993
        • Magann E.F.
        • Doherty D.A.
        • Ennen C.S.
        • et al.
        The ultrasound estimation of amniotic fluid volume in diamniotic twin pregnancies and prediction of peripartum outcomes.
        Am J Obstet Gynecol. 2007; 196: 570.e1-570.e6
        • Abbott J.G.
        Rationale and derivation of MI and TI: a review.
        Ultrasound Med Biol. 1999; 25: 431-441
        • Abramowicz J.S.
        • Barnett S.B.
        • Duck F.A.
        • Edmonds P.D.
        • Hynynen K.H.
        • Ziskin M.C.
        Fetal thermal effects of diagnostic ultrasound.
        J Ultrasound Med. 2008; 27: 541-559
        • Abramowicz J.S.
        Fetal Doppler: how to keep it safe?.
        Clin Obstet Gynecol. 2010; 53: 842-850
      2. American College of Radiology. ACR–SPR practice guideline for the safe and optimal performance of fetal magnetic resonance imaging (MRI). Revised 2010 (Resolution 13). Available at: http://www.acr.org/∼/media/ACR/Documents/PGTS/guidelines/MRI_Fetal.pdf. Accessed Feb.19, 2014.

        • Levine D.
        • Barnes P.D.
        • Madsen J.R.
        • Li W.
        • Edelman R.R.
        Fetal central nervous system anomalies: MR imaging augments sonographic diagnosis.
        Radiology. 1997; 204: 635-642
        • Whitby E.
        • Paley M.N.
        • Davies N.
        • Sprigg A.
        • Griffiths P.D.
        Ultrafast magnetic resonance imaging of central nervous system abnormalities in utero in the second and third trimester of pregnancy: comparison with ultrasound.
        BJOG. 2001; 108: 519-526
        • Kathary N.
        • Bulas D.I.
        • Newman K.D.
        • Schonberg R.L.
        MRI imaging of fetal neck masses with airway compromise: utility in delivery planning.
        Pediatr Radiol. 2001; 31: 727-731
        • Kline-Fath B.M.
        • Calvo-Garcia M.A.
        • O'Hara S.M.
        • Crombleholme T.M.
        • Racadio J.M.
        Twin-twin transfusion syndrome: cerebral ischemia is not the only fetal MR imaging finding.
        Pediatr Radiol. 2007; 37: 47-56
        • Twickler D.M.
        • Magee K.P.
        • Caire J.
        • Zaretsky M.
        • Fleckenstein J.L.
        • Ramus R.M.
        Second-opinion magnetic resonance imaging for suspected fetal central nervous system abnormalities.
        Am J Obstet Gynecol. 2003; 188: 492-496